Wei Fu

1.9k total citations
38 papers, 1.5k citations indexed

About

Wei Fu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei Fu has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Complementary and alternative medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei Fu's work include Traditional Chinese Medicine Analysis (7 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Wei Fu is often cited by papers focused on Traditional Chinese Medicine Analysis (7 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Wei Fu collaborates with scholars based in China, United States and Canada. Wei Fu's co-authors include Wenlong Bai, Santo V. Nicosia, Michael D. Schaller, Yonghua Yang, Jiandong Chen, Xiaohong Zhang, Kapil N. Bhalla, Nancy Olashaw, Yu He and Tao Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Cell Biology and Cancer Research.

In The Last Decade

Wei Fu

36 papers receiving 1.5k citations

Peers

Wei Fu
Comparison fields: 5 of 110
  • Molecular Biology 799
  • Epidemiology 216
  • Cancer Research 215
  • Oncology 212
  • Geriatrics and Gerontology 202
Si‐Chi Xu China
Qi‐Zhu Tang China
Michinari Nakamura United States
Junlian Gu China
Yu‐Pei Yuan China
Zheng Gen Jin United States
Chun‐Yan Kong China
Can Hu China
Si‐Chi Xu China View profile →
Citations per field, relative to Wei Fu
Wei Fu · 1×
Citations per year, relative to Wei Fu
Wei Fu · 1×

Countries citing papers authored by Wei Fu

Since Specialization
Citations

This map shows the geographic impact of Wei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Fu more than expected).

Fields of papers citing papers by Wei Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Fu. The network helps show where Wei Fu may publish in the future.

Co-authorship network of co-authors of Wei Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Fu. A scholar is included among the top collaborators of Wei Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Fu. Wei Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 13
4 7
5 6
6 11
7 30
8 18
9 49
10 18
11 93
12 26
13 11
14 128
15 159
16 56
17 42
18 265
19 11
20 10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026